Literature DB >> 17404841

Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells.

Stacey L Thomas1, George H De Vries.   

Abstract

Peripheral nerve sheath tumors from individuals with Neurofibromatosis Type 1 (NF1) are highly vascular and contain Schwann cells which are deficient in neurofibromin. This study examines the angiogenic expression profile of neurofibromin-deficient human Schwann cells relative to normal human Schwann cells, characterizing both pro-angiogenic and anti-angiogenic factors. Conditioned media from neurofibromin-deficient Schwann cell lines was pro-angiogenic as evidenced by its ability to stimulate endothelial cell proliferation and migration. Using gene array and protein array analysis, we found increased expression of pro-angiogenic factors and decreased expression of anti-angiogenic factors in neurofibromin-deficient Schwann cells relative to normal human Schwann cells. Neurofibromin-deficient Schwann cells also showed increased expression of several growth factor receptors and decreased expression of an integrin. We conclude that neurofibromin-deficient Schwann cells have dysregulated expression of pro-angiogenic factors, anti-angiogenic factors, growth factor receptors, and an integrin. These dysregulated molecules may contribute to the growth and progression of NF1 peripheral nerve sheath tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404841     DOI: 10.1007/s11064-007-9279-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  56 in total

Review 1.  Role of alpha v integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Cancer J       Date:  2000-05       Impact factor: 3.360

2.  Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone.

Authors:  J K Lee; B Choi; R A Sobel; E A Chiocca; R L Martuza
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

3.  Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors.

Authors:  Kouros Motamed; Sarah E Funk; Hidenori Koyama; Russell Ross; Elaine W Raines; E Helene Sage
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

4.  The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.

Authors:  A P Mazar; J Henkin; R H Goldfarb
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

5.  SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.

Authors:  C Kupprion; K Motamed; E H Sage
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

6.  Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.

Authors:  Mark A Watson; Arie Perry; Tarik Tihan; Richard A Prayson; Abhijit Guha; Julia Bridge; Rosalie Ferner; David H Gutmann
Journal:  Brain Pathol       Date:  2004-07       Impact factor: 6.508

7.  Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.

Authors:  Nikola Holtkamp; Victor-F Mautner; Reinhard E Friedrich; Anja Harder; Christian Hartmann; Agota Theallier-Janko; Karl T Hoffmann; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2003-12-13       Impact factor: 17.088

Review 8.  The role of angiogenesis in tumor growth.

Authors:  J Folkman
Journal:  Semin Cancer Biol       Date:  1992-04       Impact factor: 15.707

9.  Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.

Authors:  V Sirén; J-P Antinheimo; J Jääskeläinen; T Böhling; O Carpén; A Vaheri
Journal:  Acta Neurochir (Wien)       Date:  2003-12-22       Impact factor: 2.216

10.  Angiogenic and invasive properties of neurofibroma Schwann cells.

Authors:  S Sheela; V M Riccardi; N Ratner
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

View more
  11 in total

1.  Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas In Vitro.

Authors:  Ziang Zou; Linna Guo; Victor Mautner; Ralf Smeets; Lan Kiuwe; Reinhard E Friedrich
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  A career perspective on the discipline of neurochemistry.

Authors:  George H DeVries
Journal:  Neurochem Res       Date:  2009-01       Impact factor: 3.996

3.  Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.

Authors:  Joshua T Dilworth; Jonathan W Wojtkowiak; Patricia Mathieu; Michael A Tainsky; John J Reiners; Raymond R Mattingly; Chad N Hancock
Journal:  Cancer Biol Ther       Date:  2008-12-07       Impact factor: 4.742

4.  Schwann cells promote endothelial cell migration.

Authors:  Tiago Ramos; Maqsood Ahmed; Paul Wieringa; Lorenzo Moroni
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage.

Authors:  Markus Finzsch; Silke Schreiner; Tatjana Kichko; Peter Reeh; Ernst R Tamm; Michael R Bösl; Dies Meijer; Michael Wegner
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

6.  The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.

Authors:  Jan Zietsch; Nicolas Ziegenhagen; Frank L Heppner; David Reuss; Andreas von Deimling; Nikola Holtkamp
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

7.  Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.

Authors:  Emeline Tabouret; Aurelie Tchoghandjian; Emilie Denicolai; Christine Delfino; Philippe Metellus; Thomas Graillon; Celine Boucard; Isabelle Nanni; Laetitia Padovani; L'Houcine Ouafik; Dominique Figarella-Branger; Olivier Chinot
Journal:  Oncotarget       Date:  2015-05-10

8.  Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.

Authors:  Ritsuko Harigai; Shigeki Sakai; Hiroyuki Nobusue; Chikako Hirose; Oltea Sampetrean; Noriaki Minami; Yukie Hata; Takashi Kasama; Takanori Hirose; Toshiki Takenouchi; Kenjiro Kosaki; Kazuo Kishi; Hideyuki Saya; Yoshimi Arima
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

9.  Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.

Authors:  Su-Jin Park; Birgit Sawitzki; Lan Kluwe; Victor F Mautner; Nikola Holtkamp; Andreas Kurtz
Journal:  BMC Med       Date:  2013-04-23       Impact factor: 8.775

10.  Transcriptional regulation induced by cAMP elevation in mouse Schwann cells.

Authors:  Daniela Schmid; Thomas Zeis; Nicole Schaeren-Wiemers
Journal:  ASN Neuro       Date:  2014-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.